Trial Profile
A real world study of secukinumab in Canadian psoriasis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 May 2018 New trial record.